Prostaid

	Page
Trustees' Report	1—7
Independent Examiner's Report	8
Statement of Financial Activities (including Income and Expenditure Account)	9
Comparative Statement of Financial Activities (including Income and Expenditure Account)	10
Balance Sheet	11—12
Notes to the Financial Statements	13—22

The trustees present their report and the financial statements for the year ended 31 October 2025.

Objectives and Activities

Aims and Objectives

The Charity’s primary objectives are:

To relieve sickness, particularly prostate-related diseases, by supporting and encouraging the treatment of prostate cancer patients. This is primarily, though not exclusively, carried out with the Department of Urology, University of Leicester NHS Trust, and associated hospitals in Leicester, Leicestershire, Rutland, and Northamptonshire.

To raise public awareness of issues relating to prostate cancer.

To provide relief of suffering among men, particularly those treated for prostate cancer and related conditions, through practical support and information for patients, their families, and dependants, delivered in ways determined by the Trustees.

The Charity’s aims and activities are regularly reviewed. Trustees have developed a five-year strategy to improve organisational effectiveness and ensure long-term sustainability. This strategy was last reviewed in 2017/18, continued through 2021/22, with the next formal review planned for 2026.

Achievements and Performance

Main Achievements

Background

Prostate cancer is the most common cancer in men in the UK, accounting for 25% of all new cancer diagnoses. According to Cancer Research UK (2017–2019):

Around 55,300 new cases are diagnosed each year (approximately 150 per day).
Between 2021–2023, 12,200 men died from prostate cancer (about 34 per day).
Rates have tripled in the past 40 years due to increased detection through PSA testing. Survival rates have improved significantly: in the 1970s, only 30% of men survived five years or more, compared with 78.9% surviving ten years or more today.
However, Leicester, Leicestershire, and Rutland still experience some of the lowest five-year survival rates for aggressive prostate cancer in the UK. Local data shows that 21% of men are diagnosed with metastasised disease, spreading to bones or other areas. Currently, over 42 new cases of prostate cancer per week are diagnosed locally, compared with 18 in Northampton and 9.6 nationally(CRUK).
Many Prostaid Trustees and members are local men with personal experience of the disease. The Charity focuses on raising local awareness, improving patient care, and supporting families.

Despite challenges from high inflation and the rising cost of living and increases in taxation the Charity’s income remains positive.

Key Achievements

Funding of Prostaid Specialist Nurses

...CONTINUED

Page 1

Page 2

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Main Achievements - continued

University Hospitals of Leicester (UHL): Agreement to jointly fund three specialist nurses on a 50/50 basis from February 2023, for a three-year contract covering patients from diagnosis through oncology. Review due February 2026.
Northampton General Hospital: Specialist nurse Alice Knight’s contract renewed from 20 April 2023 for a further three years on a 50/50 basis, with renewal due in April 2026.
Former nurse Aimee Winfield, now Sister in Ward 28A, remains a Trustee and continues work on trans perineal biopsies using Charity-funded equipment, reducing patient waiting times.
Former Specialist Nurse Jo Wortley continues as Lead Nurse at UHL, supported by Charity-funded team members Aro Fernando, Alison Leggate, and Rebecca Mills.

UHL now has the largest prostate cancer nurse cohort in the UK, a legacy of Prostaid’s pioneering support.

Professional Training

Northampton Prostate Cancer Nurse training has been delayed due to staff shortages, but integration with UHL under the University Hospitals of Northampton from July 2024 is expected to enable full training.
UHL and Prostaid continue to support ongoing professional development for specialist nurses.

Raising Awareness

Prostaid organised events at workplaces, community centres, and public venues including Samworth, GE Baker Perkins, LCFC, Leicester Racecourse, Leicester Caribbean Club, Orbit Buses, and the Ukulele Orchestra.
Planned for 2026: Arriva Awareness Buses to reach a wider county audience.
Special focus on men of African descent, who face a 1 in 4 lifetime risk of prostate cancer. Collaborations included the Pamela Campbell Morris Health Trust and African Caribbean Health Forum.

United Against Prostate Cancer (UAPC)

Prostaid contributed to NHS England’s East Genomic Medicine Service Alliance project, completed October 2023.
Local pathology and histology services now allow genetic cancer biopsy testing in Leicester and Cambridge, benefiting men at higher risk, particularly those of African descent.

Patient Information and Resources

Leaflets produced on hormone treatment, bone health, gut health, travel insurance, brachytherapy, and PSA records, distributed across hospitals and Macmillan Cancer Information Centres.
Radiotherapy Preparation Cards and support group leaflets developed.
Patient folders provided, including invitation letters, treatment options, buddy leaflets, PSA record cards, and newsletters.

Da Vinci Robot

...CONTINUED

Page 2

Page 3

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Main Achievements - continued

The £2 million Da Vinci Robot appeal (2014) continues to improve prostate surgery outcomes, with over 7,000 procedures completed.
New robot equipment is planned for Leicester General Hospital.

John van Geest Centre (JVG)

Trustees maintain collaboration with Nottingham Trent University’s £15 million Prostate & Breast Cancer Research Centre and participate in immunotherapy trials.

Website and Digital Presence

Website improvements include mobile optimisation and a “Get Involved” section.
Office 365 now provides Trustees with access to Charity archives.

Friends & Forum

Support networks and volunteer services continue to develop.
Plans for a Prostaid Forum to incorporate support group ideas remain ongoing.

Collaborations

Partnerships include UHL Genetics, Macmillan, LOROS, Northampton & Kettering Hospitals, Nuffield and Spire Hospitals, Prostate Cancer UK, Tackle Prostate Cancer, and University of Leicester researchers.

Social Events and Well-being

Christmas parties, curry evenings, and the Glen Gorse Walking Club organised five healthy walks.

Support Groups

Four support groups in Leicester, Melton, Birstall, and Northampton continue to grow.
Collaboration with Birstall Bags (a breast cancer charity) supports a unique joint group.
African/Caribbean group to relaunch with support from Howard Morris.
Southern Asian support group on hold due to increased attendance in existing groups.

Brachytherapy

HDR (High Dose Rate) and LDR (seeded) Brachytherapy will soon be available at Leicester Royal Infirmary, reducing treatment times and improving outcomes.
Charity-supported leaflets and video content continue to educate patients.

Page 3

Page 4

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Fundraising and Finance

Successful events included the Prostaid Golf Day, local fund raising, memorial football match, Dragon Boat Race (£15k), and the Freeze Your Bits and Bobs Off sponsored walk.

Dedicated Prostaid Prostate Cancer Centre

Plans for 2025–26 include additional high-profile fundraising events.
Work continues towards a specialist Prostate Centre in Leicester, with support from UHL and Trustees. Fundraising is planned to complete by Autumn 2026.
The proposed centre, to be called ‘The Prostate Centre’, received full written support from Chief Executive Richard Mitchell of UHL.
Leadership team: Mr Anthony Bates (UHL Urologist and Clinical Lead), Chair Jonathan Kerry, Rob Banner, and Fundraising Manager Anna Price.
A meeting with UHL in January 2026 will finalise the location to enable our fundraising programme to complete by Autumn 2026.

Newsletter and Leaflets

Biannual newsletter continues, supported by Birdhouse. Leaflets distributed to hospitals, GP surgeries, and public noticeboards across Leicester, Leicestershire, Rutland, Kettering, and Northampton.

Financial Review

Fundraising and Finance

Fundraising income increased despite post-pandemic and economic challenges.
Reserves Policy: Minimum 12 months’ operating costs retained, with additional funds earmarked for ongoing projects.
Expected pending legacies include £70k from the Toyne legacy

Structure, Governance and Management

Governing Document

Charity governed by Memorandum and Articles of Association.
Incorporated: 2 October 2006; Registered Charity: 22 November 2006.
Trustees meet 4–6 times annually.
Legal advice confirms fundraising for the Prostate Centre can continue under existing governing documents, with a separate bank account.

Patrons

...CONTINUED

Page 4

Page 5

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Governing Document - continued

Richard Everard DL OBE
Alan Birchenall MBE
Patrons provide ongoing support and promotion of Charity objectives.

Recruitment of Trustees

Appointments in 2025: Jonathan Kerry (Chair), Jang Akhtar, Suds Bhatt.
Resignations: Mark Dunkley (Chair, June 2025), Peter Hayes (May 2025).

Management

One full-time employed Trustee, Robert Banner, oversees operations.
Honorary Treasurer: Dave Merriman; Assistant Treasurer: Faye Lord (bookkeeping and social media).
Other key roles include Buddy Coordinators, Friends Coordinator, Awareness Coordinator, Fundraising Coordinator, and support group leads, ensuring smooth operations and direct patient support.

Volunteers

Total volunteer hours: 1,860 hours in 2024–25, supporting patient care and services.

Risk Management

Trustees regularly assess risks and implement appropriate mitigation measures.

Reference and Administrative Details

Trustees

Mr Jonathan Kerry (Chair) (appointed 30/07/2025)

Mr John Bird (Vice chair)

Mr Robert Banner

Mr David Merriman (Treasurer)

Mrs Aimee Winfield

Mr Anthony Bates

Mr Christopher Kent

Mr Jehngir Akhtar (appointed 30/07/2025)

Mrs Joanne Wortley

Mr Scott McLaren

Mr Sudhir Bhatt (appointed 30/07/2025)

Mr Graydon Thwaite (resigned 21/01/2025)

Mr Mark Dunkley (resigned 06/06/2025)

Mr Peter Ross (resigned 02/05/2025)

Mr Stuart Berry

Page 5

Page 6

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Company Secretary

Mr Robert Banner

Charity Number

1116935

Company Number

05953090

Principal Address

17 Torrington Close

Wigston

Leicester

Leicestershire

LE18 2RY

Registered Office

17 Torrington Close

Wigston

Leicester

Leicestershire

LE18 2RY

Independent Examiner

Martyn Griffiths FCCA

Blackthorn Griffiths Limited

Chartered Certified Accountants

Valley View Wood Lane
Tugby
Leicester
LE7 9WE

Page 6

Page 7

Prostaid

Trustees' Report (continued)

For The Year Ended 31 October 2025

Statement of Trustees' Responsibilities

The trustees (who are also the directors of Prostaid for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statement unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing the financial statements the trustees are required to:

select suitable accounting policies and then apply them consistently;
observe the methods and principles in the Charity SORP;
make judgments and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The trustees are responsible for keeping adequate accounting records which disclose with reasonable accuracy at anytime the financial position of the charitable company and to enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Small Company Rules

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The trustees' report was approved by the board of trustees and signed on its behalf by:

Mr Robert Banner Trustee	Mr David Merriman (Treasurer) Trustee
28th January 2026

Page 7

Page 8

Prostaid

Independent Examiner's Report to the Trustees of Prostaid

For The Year Ended 31 October 2025

Independent Examiner's Report to the Trustees of Prostaid

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 October 2025.

Responsibilities and Basis of Report

As the charity trustees of the Company (and also its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent Examiner's Statement

Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of ACCA, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
the accounts do not accord with those records; or
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination; or
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Martyn Griffiths FCCA

28th January 2026

Valley View Wood Lane
Tugby
Leicester
LE7 9WE

Page 8

Page 9

Prostaid

Statement of Financial Activities (including Income and Expenditure Account)

For The Year Ended 31 October 2025

Statement of Financial Activities (including Income and Expenditure Account)

				2025	2024
		Unrestricted funds	Restricted funds	Total funds	Total funds
	Notes	£	£	£	£
INCOME AND ENDOWMENTS FROM:
Donations and legacies	4	144,276	-	144,276	233,924
Charitable activities:
Other fund raising activities		23,763	-	23,763	17,369
Investments	5	2,196	-	2,196	5,145

		170,235	-	170,235	256,438

EXPENDITURE ON:
Charitable activities:	7
Other events		(9,458 )	-	(9,458 )	(5,723 )
Direct costs		(156,963 )	-	(156,963 )	(183,005 )
Other		(27,332 )	-	(27,332 )	(24,203 )

		(193,753 )	-	(193,753 )	(212,931 )

NET (EXPENDITURE)/INCOME		(23,518 )	-	(23,518 )	43,507


NET MOVEMENT IN FUNDS		(23,518 )	-	(23,518 )	43,507
RECONCILIATION OF FUNDS:
Total funds brought forward		312,260	42,369	354,629	311,122

TOTAL FUNDS CARRIED FORWARD	14	288,742	42,369	331,111	354,629

The notes on pages 13 to 20 form part of these financial statements.

Page 9

Page 10

Prostaid

Comparative Statement of Financial Activities (including Income and Expenditure Account)

For The Year Ended 31 October 2025

Comparative Statement of Financial Activities (including Income and Expenditure Account)

				2024
		Unrestricted funds	Restricted funds	Total funds
	Notes	£	£	£
INCOME AND ENDOWMENTS FROM:
Donations and legacies	4	233,924	-	233,924
Charitable activities:
Other fund raising activities		17,369	-	17,369
Investments	5	5,145	-	5,145

		256,438	-	256,438

EXPENDITURE ON:
Charitable activities:	7
Other events		(5,723 )	-	(5,723 )
Direct costs		(183,005 )	-	(183,005 )
Other		(24,203 )	-	(24,203 )

		(212,931 )	-	(212,931 )

NET INCOME		43,507	-	43,507


NET MOVEMENT IN FUNDS		43,507	-	43,507
RECONCILIATION OF FUNDS:
Total funds brought forward		268,753	42,369	311,122

TOTAL FUNDS CARRIED FORWARD	14	312,260	42,369	354,629

The notes on pages 13 to 20 form part of these financial statements.

Page 10

Page 11

Prostaid

Balance Sheet

As At 31 October 2025

Balance Sheet

				2025	2024
		Unrestricted funds	Restricted funds	Total funds	Total funds
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	11	-	-	-	134

		-	-	-	134
CURRENT ASSETS
Debtors	12	72,675	-	72,675	91,750
Cash at bank and in hand		228,124	42,369	270,493	274,216

		300,799	42,369	343,168	365,966
Creditors: Amounts Falling Due Within One Year	13	(12,057 )	-	(12,057 )	(11,471 )

NET CURRENT ASSETS (LIABILITIES)		288,742	42,369	331,111	354,495

TOTAL ASSETS LESS CURRENT LIABILITIES		288,742	42,369	331,111	354,629

NET ASSETS		288,742	42,369	331,111	354,629

FUNDS OF THE CHARITY
Restricted Funds				42,369	42,369
Unrestricted Funds				288,742	312,260

TOTAL FUNDS	14			331,111	354,629

Page 11

Page 12

Prostaid

Balance Sheet (continued)

As At 31 October 2025

For the year ending 31 October 2025 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board

Mr Robert Banner Trustee	Mr David Merriman (Treasurer) Trustee
28th January 2026

The notes on pages 13 to 20 form part of these financial statements.

Page 12

Page 13

Prostaid

Notes to the Financial Statements

For The Year Ended 31 October 2025

Notes to the Financial Statements

1. General Information

Prostaid is a company limited by guarantee, incorporated in England & Wales, registered number 05953090 and registered charity number 1116935 . The registered office is 17 Torrington Close, Wigston, Leicester, Leicestershire, LE18 2RY.

2. Statement of Compliance

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. Accounting Policies

3.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention.

The charitable company is a Public Benefit Entity as defined by FRS 102.

3.2. Going Concern Disclosure

The trustees have not identified any material uncertainties related to events or conditions that may cast significant doubt about the charitable company's ability to continue as a going concern.

3.3. Fund Accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

3.4. Incoming Resources

All income is recognised once the company has entitlement to the income, it is probable that all the income will be received and the amount of income receivable can be measured reliably.

Donated services or facilities are recognised when the company has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from use by the company of the item is probable and the economic benefit can be measured reliably. In accordance with the Chanties SORP (FRS 102), the general volunteer time of the Friends is not recognised and refer to the Trustees' report for more information about their contribution.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the company which is the amount the company would have been willing to pay to obtain services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

...CONTINUED

Page 13

Page 14

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

3.4. Incoming Resources - continued

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

3.5. Resources Expended

Expenditure is recognised once there is a legal or consecutive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settllement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of a total of direct costs and shared costs, including support costs involved in undertaking each activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset's use.

Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the company and compliance with constitution and statutory requirements.

Charitable activities and Governance costs are incurred on the company's educational operations, including support costs and costs relating to the governance of the company, apportioned to charitable activities.

3.6. Tangible Fixed Assets and Depreciation

All assets costing more than £250 are capitalised.

A review for impairment of a fixed asset is carried out if events or changes in circumstances indicate that the carrying value of any fixed asset may not be recoverable. Shortfalls between the carrying value of fixed assets and their recoverable amounts are recognised as impairments. Impairment losses are recognised in the Statement of financial activities incorporating income and expenditure account.

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings	five years
Computer Equipment	three years

3.7. Financial Instruments

The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instrument are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

3.8. Taxation

The charity is exempt from corporation tax on its charitable activities.

4. Income from Donations and Legacies

Page 14

Page 15

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

	2025	2024
	Unrestricted	Unrestricted
	funds	funds
	£	£
Donations and gifts:
General donations (incl Gift Aid)	101,196	191,430
Legacies and funeral donations	7,369	3,127
Donations in kind	24,644	28,282
Dragon Boat race	11,067	11,085

	144,276	233,924

5. Investment Income

	2025	2024
	Unrestricted	Unrestricted
	funds	funds
	£	£
Bank interest receivable	2,196	5,145

6. Net Income/(Expenditure)

The net (expenditure)/income is stated after charging/(crediting):

	2025	2024
	£	£
Depreciation of tangible fixed assets - owned	134	192

7. Analysis of Expenditure

			2025
	Activities undertaken directly	Support costs (see note 8 )	Total
	£	£	£
Other events	7,832	1,626	9,458
Direct costs	111,769	45,194	156,963
Other	27,332	-	27,332

	146,933	46,820	193,753

Page 15

Page 16

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

			2024
	Activities undertaken directly	Support costs (see note 8 )	Total
	£	£	£
Other events	5,723	-	5,723
Direct costs	137,624	45,381	183,005
Other	24,203	-	24,203

	167,550	45,381	212,931

8. Support Costs

			2025
	Other events	Direct costs	Total
	£	£	£
Employee costs	-	907	907
Premises expenses	-	3,065	3,065
General administration	1,626	41,088	42,714
Depreciation	-	134	134

	1,626	45,194	46,820

	2024
	Direct costs
	£
Employee costs	1,080
Premises expenses	2,722
General administration	41,387
Depreciation	192

	45,381

Page 16

Page 17

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

9. Staff Costs

Staff costs were as follows:

	2025	2024
	£	£
Wages and salaries	25,514	24,203
Social security costs	1,818	-

	27,332	24,203

No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000.

10. Average Number of Employees

Average number of employees during the year was: 1 (2024: 1)

11. Tangible Assets

	Fixtures & Fittings	Computer Equipment	Total
	£	£	£
Cost
As at 1 November 2024	4,835	14,087	18,922
Disposals	-	(13,763 )	(13,763 )

As at 31 October 2025	4,835	324	5,159

Depreciation
As at 1 November 2024	4,728	14,060	18,788
Provided during the period	107	27	134
Disposals	-	(13,763 )	(13,763 )

As at 31 October 2025	4,835	324	5,159

Net Book Value
As at 31 October 2025	-	-	-

As at 1 November 2024	107	27	134

12. Debtors

	2025	2024
	£	£
Due within one year
Donations receivable	72,050	91,125
Other debtors	625	625

	72,675	91,750

Page 17

Page 18

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

13. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	78	292
Other creditors	54	-
Taxation and social security	2,299	470
Accruals and deferred income	9,626	10,709

	12,057	11,471

14. Movement in Funds

	As at 1 November 2024	Income	Expenditure	As at 31 October 2025
	£	£	£	£
Unrestricted funds
General:
General unrestricted fund	307,938	170,235	(193,753)	284,420
Northampton	2,370	-	-	2,370
Support Groups	1,952	-	-	1,952


Total unrestricted funds	312,260	170,235	(193,753 )	288,742


Restricted funds
Brachytherapy	3,000	-	-	3,000
Website videos	250	-	-	250
United Against Prostate Cancer	39,119	-	-	39,119


Total restricted funds	42,369	-	-	42,369




Total funds	354,629	170,235	(193,753 )	331,111

	As at 1 November 2023	Income	Expenditure	As at 31 October 2024
	£	£	£	£
Unrestricted funds
General:
General unrestricted fund	264,431	256,438	(212,931)	307,938
Northampton	2,370	-	-	2,370

...CONTINUED

Page 18

Page 19

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

Support Groups	1,952	-	-	1,952


Total unrestricted funds	268,753	256,438	(212,931 )	312,260


Restricted funds
Brachytherapy	3,000	-	-	3,000
Website videos	250	-	-	250
United Against Prostate Cancer	39,119	-	-	39,119


Total restricted funds	42,369	-	-	42,369




Total funds	311,122	256,438	(212,931 )	354,629

15. Transactions with Trustees

The following trustees have been paid remuneration or have received other benefits from the charity or related entity:

Name of trustee	Legal authority	Remuneration	2025 Total
		£	£
Mr Robert Banner	Governing document provision	27,332	27,332

During the previous year the following trustees have been paid remuneration or have received other benefits from the charity or a related entity:

Name of trustee	Legal authority	Remuneration	2024 Total
		£	£
Mr Robert Banner	Governing document provision	24,203	24,203

No trustee expenses have been incurred.

16. Related Party Disclosures

There have been no related party transactions in the reporting period that require disclosure, except for those disclosed in the Transactions with Trustees note.

Page 19

Page 20

Prostaid

Notes to the Financial Statements (continued)

For The Year Ended 31 October 2025

17. Company limited by guarantee

The company is limited by guarantee and has no share capital.

In the event of the company being wound up, the liability in respect of the guarantee is limited to £10 per member of the company.

Page 20

Page 21

Prostaid

Detailed Statement of Financial Activities (including Income and Expenditure Account)

For The Year Ended 31 October 2025

Detailed Statement of Financial Activities (including Income and Expenditure Account)

	2025	2024
	Total funds	Total funds
	£	£
INCOME AND ENDOWMENTS FROM:
Donations and legacies

General donations (incl Gift Aid)	101,196	191,430
Legacies and funeral donations	7,369	3,127
Donations in kind	24,644	28,282
Dragon Boat race	11,067	11,085

	144,276	233,924

Charitable Activities:
Other fund raising activities
Golf days	15,945	11,507
Other events	1,045	3,294
Christmas party	2,635	1,568
UAPC	-	1,000
Curry night	4,138	-

	23,763	17,369
Investments

Bank interest receivable	2,196	5,145

	2,196	5,145


	170,235	256,438
EXPENDITURE ON:
Charitable Activities:
Other events
Dragon Boat race costs	(7,832)	(5,723)
Curry night costs	(1,626)	-

	(9,458)	(5,723)
Direct costs
General fundraising costs	(13,999)	(15,080)
Nurse's salaries	(97,770)	(122,544)
Travel expenses	(907)	(1,080)
Insurance costs	(3,065)	(2,722)
Gift and services in kind	(24,644)	(28,282)
Independent examiner's fees	(3,420)	(3,095)
Accountancy fees	(1,815)	(1,857)
Professional fees	(35)	-
Bank charges	(374)	(258)

...CONTINUED

Page 21

Page 22

Prostaid

Detailed Statement of Financial Activities (including Income and Expenditure Account) (continued)

For The Year Ended 31 October 2025

Other
Office expenses	(6,104)	(4,405)
Support group expenses	(4,696)	(2,811)
Curry night costs	-	(679)
Depreciation of fixtures and fittings	(107)	(84)
Depreciation of computer equipment	(27)	(108)

	(156,963)	(183,005)
Trustees' salaries	(25,514)	(24,203)
Trustees' NI	(1,818)	-

	(27,332)	(24,203)

	(193,753)	(212,931)

NET (EXPENDITURE)/INCOME	(23,518)	43,507

Page 22